key: cord-1048539-niqka1hh
authors: Hariyanto, Timotius Ivan; Putri, Cynthia; Arisa, Jessie; Situmeang, Rocksy Fransisca V.; Kurniawan, Andree
title: Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Systematic Review and Meta-Analysis
date: 2020-11-19
journal: Arch Gerontol Geriatr
DOI: 10.1016/j.archger.2020.104299
sha: 7404ccacc2c6ce86a315f3782004dbafe221a3ef
doc_id: 1048539
cord_uid: niqka1hh

BACKGROUND: The number of positive and death cases from coronavirus disease 2019 (COVID-19) is still increasing until now. One of the most prone individuals, even in normal situations is patients with dementia. Currently, no study provides clear evidence regarding the link between dementia and COVID-19. This study aims to analyze the relationship between dementia and poor outcomes of COVID-19 infection. MATERIALS AND METHODS: We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until October 25(th), 2020. All articles published on COVID-19 and dementia were retrieved. The quality of the study was assessed using the Newcastle Ottawa Scale (NOS) tool for observational studies. Statistical analysis was done using Review Manager 5.4 software. RESULTS: A total of 24 studies with 46,391 dementia patients were included in this meta-analysis. This meta-analysis showed that dementia was associated with composite poor outcome [RR 2.67 (95% CI 2.06 – 3.47), p < 0.00001, I(2) = 99%, random-effect modelling] and its subgroup which comprised of risk of COVID-19 infection [RR 2.76 (95% CI 1.43 – 5.33), p = 0.003, I(2) = 99%, random-effect modelling], severe COVID-19 [RR 2.63 (95% CI 1.41 – 4.90), p = 0.002, I(2) = 89%, random-effect modelling], and mortality from COVID-19 infection [RR 2.62 (95% CI 2.04 – 3.36), p < 0.00001, I(2) = 96%, random-effect modelling]. CONCLUSIONS: Extra care and close monitoring should then be provided to patients with dementia to minimize the risk of infections, preventing the development of severe and mortality outcomes.

World Health Organization (WHO) first declared coronavirus disease 2019 (COVID- 19) as a pandemic in March 2020, and now, seven months after that, the number of positive and death cases are still increasing. This global pandemic has caused a significant impact on health, social, and economic aspects around the world. Thus, identification of the risk factors that contribute to the development of severe infections is important to enabling risk stratification, optimizing the hospital resources reallocation, and guiding public health recommendations and interventions. [1] Several comorbidities have been demonstrated to be associated with severe COVID-19 outcomes such as hypertension, diabetes, dyslipidemia, anemia, cardiovascular disease, thyroid disease, and pulmonary disease. [2] [3] [4] [5] During normal times, individuals with dementia are the most vulnerable persons as they depend on other people for their day to day survival. In a previous study, it has been shown that dementia increases the risk of morbidity and mortality among hospitalized patients, including the severity of the respiratory disease. [6] Unfortunately, until now, no study provides clear evidence regarding the link between dementia and COVID-19. This article aims to explore the potential association between dementia and poor outcomes of COVID-19 infection.

Studies were included in this review if met the following inclusion criteria: representation for clinical questions (P: positive/confirmed cases of COVID-19; I: a group of patients with dementia as their comorbidity; C: a group of patients without dementia; O: composite poor outcomes which comprise of risk of COVID-19 infection, severe COVID-19, and mortality), type of study was a randomized control trial, cohort, clinical trial, case-cohort, and cross-over design, and if the full-text article was available. The following types of articles were excluded: articles other than original research (e.g., review articles, letters, or commentaries); case reports;

articles not in the English language; articles on research in pediatric populations (17 years of age or younger); and articles on research in pregnant women.

A systematic search of the literature was conducted on PubMed and Europe PMC using the keywords "dementia" OR "major cognitive impairment" OR "clinical characteristics" OR "comorbidities" OR "risk factors" AND "coronavirus disease 2019" OR "COVID-19", between 2019 and present time (October 25 th , 2020) with language restricted to English only. The title, abstract, and full text of all articles identified that matched the search criteria were assessed, and those reporting the rate of dementia in COVID-19 patients with a clinically validated definition of "severe disease" and "mortality" were included in this meta-analysis. The references of all identified studies were also analyzed (forward and backward citation tracking) to identify other potentially eligible articles. The study was carried out per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. [7] 

Data extraction was performed independently by two authors, we used standardized forms that include author, year, study design, number of participants, age, gender, number of patients with dementia, and proportion of patients with each outcome of COVID-19. Two investigators independently evaluated the quality of the included cohort and casecontrol studies using the Newcastle-Ottawa Scale (NOS). [8] The selection, comparability, and exposure of each study were broadly assessed and studies were assigned a score from zero to nine. Studies with scores ≥7 were considered of good quality.

A meta-analysis was performed using Review Manager 5.4 (Cochrane Collaboration) software. Dichotomous variables were calculated using the Mantel-Haenszel formula with a random-effects model regardless of heterogeneity. The effect estimate was reported as risk ratio (RR) along with its 95% confidence intervals (CIs) for dichotomous variables, respectively. Pvalue was two-tailed, and the statistical significance was set at ≤0.05. Subgroup analysis was performed for each component of composite poor outcomes. We performed Begg"s funnel-plot analysis to qualitatively assess the risk of publication bias.

A total of 10,260 records were obtained through systematic electronic searches. After the removal of duplicates, 5,370 records remained. A total of 5,332 records were excluded after screening the titles/abstracts because they did not match our inclusion and exclusion criteria.

After evaluating 38 full-texts for eligibility, 6 full-text articles were excluded because they do not have the control/comparison group, 5 full-text articles were excluded because they do not have the outcome of interest (risk of COVID-19 infection, severe COVID-19, and mortality), 3

full-text articles were excluded because the articles were not in English, and finally, 24 studies with a total of 4,648,247 sample size and 46,391 dementia patients were included in the metaanalysis (Figure 1 ). Of a total of 24 included studies, 21 were retrospective cohort, 2 studies were prospective cohort, while the remaining 1 study was a case-control study. The essential characteristics of the included studies are summarized in Table 1 .

Studies with various study designs including cohort and case-control were included in this review and assessed accordingly with the appropriate scale or tool. Newcastle Ottawa Scales (NOS) were used to assess the cohort and case-control studies ( Table 2 ). All included studies were rated "good". In conclusion, all studies were seemed fit to be included in the meta-analysis.

Our pooled analysis showed that dementia was associated with composite poor outcome [RR 2.67 (95% CI 2.06 -3.47), p < 0.00001, I 2 = 99%, random-effect modelling] (Figure 2 

The funnel-plot analysis showed a qualitatively symmetrical inverted funnel-plot for the association between dementia and composite poor outcome (Figure 3) , showing no indication of publication bias.

Based on our pooled analysis of available data, dementia seems to be associated with an enhanced risk of severity and mortality from COVID-19 infection. Several reasons can be proposed to explain this result. First, most of the patients with dementia were old and have other comorbid medical conditions that could increase the severity of infections. Older patients with COVID-19 infection tend to present with atypical symptoms. They may be afebrile with nonrespiratory symptoms, such as delirium or isolated functional decline without any obvious physical symptoms. [33] These atypical presentations of COVID-19 may impede the early recognition of the disease, increase COVID-19 spread, and mortality. Moreover, in a metaanalysis of 611,583 COVID-19 patients, age over 60 years was found to be a risk factor for disease progression. [34] This fact could be influenced by both the physiological aging process and, especially, the greater prevalence in older adult patients of frailty and comorbidities that contribute to a decrease in functional reserve that reduces intrinsic capacity and resilience and hinders the fight against infections. [34] Older people will have a condition called "immune senescence" which consist of (1) decreased neutrophil phagocytosis and oxidative burst; (2) decreased macrophages chemotaxis and phagocytosis; and (3) decreased number of peripheral naïve T and B cells which will lead to a reduced ability to respond to new antigen. [35] Not only that, comorbidities such as cardiovascular disease, hypertension, and diabetes are highly prevalent in older adults and have been associated with worse outcomes in COVID-19. [34] Second, patients with dementia were associated with the ApoE e4 genotype. [36] ApoE itself has lipoprotein function and modulates the macrophage pro/anti-inflammatory phenotypes [37] and is expressed by many cell types in the lung, including macrophages, type I and type II alveolar epithelial cells [38] , therefore it is possible that having one or two copies of ApoE4 can increase the risk of having severe COVID-19 infection by robust innate immune response and cytokine storm that results in acute respiratory distress syndrome (ARDS). Third, inflammation also plays an important role in the pathogenesis of dementia. In addition to amyloid protein, inflammatory molecules, including acute inflammatory reactants and inflammatory cytokines, have been found in the cerebrospinal fluid of dementia patients. [39, 40] These persistent inflammatory state of dementia patients may be the cause of the increased peripheral blood white blood cells (WBC) and neutrophil counts in dementia patients with COVID-19. [14] On the other side, a meta-analysis study has shown that a high level of leukocyte counts and the high neutrophil-lymphocyte ratio was associated with a higher risk of developing severe COVID-19 and mortality from COVID-19. [41] Finally, people with dementia, due to the nature of their cognitive decline, would require the care and support of carers such as dementia caregivers in order to be able to follow healthcare and preventive measures such as wearing face masks and washing their hands with water and soap or hand sanitizers. [42] However, during this COVID-19 pandemic, the availability of caregivers becomes limited which may cause dementia patients unable to follow healthcare and preventive measures therefore making them posed a higher risk of contracting an infection from COVID-19. [43] The limitation of this study is that the presence of confounding factors such as patients' age, other comorbid conditions, nutritional status, and daily medication that can affect the relationship between dementia and mortality from COVID-19 should still be considered.

However, with this study, we hope that dementia can further be considered as an important factor and comorbidity in COVID-19 patients.

Hence, patients with dementia should be given extra care and monitoring to minimize exposure to the virus. Physicians can use the telemedicine-based practice to provide care and evaluations for dementia patients to minimize their visit to the hospitals. Physicians and caregivers should also be engaged in close monitoring of dementia patients with suspected COVID-19, for early diagnosis and treatment to avoid severe infections. The hospitals can provide Special Care Geriatric COVID-19 units for dementia and elderly patients who contract with COVID-19, which is filled with a team of mental health professionals (doctors, nurses, and psychological counselors), to give better care, more strict monitoring, and enable the healthcare providers in that units to focus only on the management of dementia patients so that the Atkins JL et al. [9] 2020 Cohort *** ** *** 8 Good

Bianchetti A et al. [10] 2020 Cohort ** ** *** 7 Good

Covino M et al. [11] 2020 Cohort *** ** *** 8 Good

Docherty AB et al. [12] 2020 Cohort **** ** *** 9 Good

Giorgi-Rossi P et al. [13] 2020 Cohort *** ** *** 8 Good

Harrison SL et al. [14] 2020 Cohort *** ** *** 8 Good

Hong KS et al. [15] 2020 Cohort ** ** *** 7 Good

Hwang J et al. [16] 2020 Cohort *** ** *** 8 Good

Jang JG et al. [17] 2020 Cohort *** ** *** 8 Good

Ji W et al. [18] 2020 Case-control *** ** *** 8 Good

Kabarriti et al. [19] 2020 Cohort *** ** *** 8 Good

Knights H et al. [20] 2020 Cohort ** ** *** 7 Good

Kokoszka-Bargiel I et al. [21] 2020 Cohort *** ** *** 8 Good

Lee JY et al. [22] 2020 Cohort ** ** *** 7 Good

Miyashita S et al. [23] 2020 Cohort ** ** *** Mohamed MO et al. [24] 2020 Cohort ** ** *** 7 Good

Moon SS et al. [25] 2020 Cohort ** ** *** 7 Good

Nystad W et al. [26] 2020 Cohort *** ** *** 8 Good

Poblador-Plou B et al. [27] 2020 Cohort *** ** *** 8 Good

Rozenfeld Y et al. [28] 2020 Cohort *** ** *** 8 Good

Sapey E et al. [29] 2020 Cohort **** ** *** 9 Good

Sung HK et al. [30] 2020 Cohort *** ** *** 8 Good

Wan Y et al. [31] 2020 Cohort *** ** *** 8 Good

Yang X et al. [32] 2020 Cohort *** ** *** 

Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -A systematic review, meta-analysis, and metaregression

Coronavirus disease 2019 and cardiovascular system: A narrative review

Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection

Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection

Dementia increases severe sepsis and mortality in hospitalized patients with chronic obstructive pulmonary disease

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank

Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort

Clinical presentation of COVID19 in dementia patients

Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: A brief descriptive study

Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study

Prognostic factors for severe coronavirus disease 2019 in Daegu

Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a nationwide case-control study

Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center

Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK

Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study

Epidemiological and clinical characteristics of coronavirus disease

Impact of dementia on clinical outcomes in elderly patients with coronavirus 2019 (COVID-19): an experience in New York

Sex Differences in Mortality Rates and Underlying Conditions for COVID-19 Deaths in England and Wales

Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals

Underlying conditions in adults with COVID-19

Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain

A model of disparities: risk factors associated with COVID-19 infection

All clinicians and students at University Hospitals Birmingham NHS Foundation Trust. Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area

Korea National Committee for Clinical Management of COVID-19. Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea

Prognosis analysis of patients with mental disorders with COVID-19: a single-center retrospective study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Coronavirus disease 2019 in geriatrics and longterm care: The ABCDs of COVID -19

The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention. Front Immunol

ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants

Apolipoprotein E -A multifunctional protein with implications in various pathologies as a result of its structural features

Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects

The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review

Inflammation as a central mechanism in Alzheimer's disease

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

The behavioral pattern of patients with frontotemporal dementia during the COVID-19 pandemic

Caring for Caregivers During COVID-19

Forest plot that demonstrates the association of dementia with composite poor outcome and its subgroup which comprises of risk of COVID-19 infection, severe COVID-19, and mortality